Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outer membrane vesicles as platform vaccine technology

1 Sept 2015

Abstract excerpt

Outer membrane vesicles (OMVs) are released spontaneously during growth by many Gram-negative bacteria. They present a range of surface antigens in a native conformation and have natural properties like immunogenicity, self-adjuvation and uptake by immune cells which make them attractive for application as vaccines against pathogenic bacteria. In particular with Neisseria meningitidis, they have been investigated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Pneumonia and Respiratory Infections
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26912077
DOI: 10.1002/biot.201400395

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outer membrane vesicles as platform vaccine technologyPMID 26912077Read ↗

Outer Membrane Vesicle Vaccine PlatformsSemantic proximity Read ↗

Potential of bacterial outer membrane vesicles in tumor vaccine: characteristics, advancements, and future directionsSemantic proximity Read ↗

Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants.Semantic proximity Read ↗

Outer membrane vesicle vaccinesSemantic proximity Read ↗

Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles.Semantic proximity Read ↗

Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process.Semantic proximity Read ↗

Novel approaches to Neisseria meningitidis vaccine designSemantic proximity Read ↗

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial VaccinesSemantic proximity Read ↗

Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254Semantic proximity Read ↗

GMMA-Based Vaccines: The Known and The UnknownSemantic proximity Read ↗

Bacterial outer membrane vesicles: New insights and applicationsSemantic proximity Read ↗

Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strainsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.